Certified by Founder Lodge
S32
United States - Silicon Valley, CA
INVESTOR
1 Disclosed Funding Rounds $125,000,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
S32 is a venture capital firm investing at the frontiers of technology, healthcare and the life sciences with focus areas including biotechnology, therapeutics, advanced diagnostics, precisio
| Company | Date | Round | Raised |
|---|---|---|---|
 Cohere |
February, 20 ,2022 | Series B | $125,000,000 |
 Function Oncology |
April, 13 ,2023 | Series A | $28,000,000 |
 AltPep |
June, 26 ,2023 | Series B | $53,000,000 |
 Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
 Endor Labs |
August, 04 ,2023 | Series A | $70,000,000 |
 Nusano |
October, 02 ,2024 | Series C | $115,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
